Crocetin improves the insulin resistance induced by high-fat diet in rats

British Journal of Pharmacology

Volumn 154, Issue 5, 2008, Pages 1016-1024

  Sheng, L ^a   Qian, Z ^a   Shi, Y ^a   Yang, L ^a   Xi, L ^b   Zhao, B ^a   Xu, X ^a   Ji, H ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Crocetin; Fatty acid clearance; Insulin resistance; Lipoprotein lipase; Peroxisome proliferator activated receptor

Indexed keywords

ACYL COENZYME A; ALBUMIN; CARNITINE PALMITOYL TRANSFERASE 1; CROCETIN; DIACYLGLYCEROL; ETOMOXIR; FATTY ACID; LIPOPROTEIN LIPASE; LIVER TRIACYLGLYCEROL LIPASE; LOW DENSITY LIPOPROTEIN; MESSENGER RNA; PALMITIC ACID C 14; PALMITIC ACID DERIVATIVE; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR ALPHA; REGULATOR PROTEIN; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ISOLATION; DRUG MECHANISM; DRUG STRUCTURE; ENZYME ACTIVITY; FAT TOLERANCE TEST; FATTY ACID BLOOD LEVEL; FATTY ACID METABOLISM; FATTY ACID OXIDATION; FATTY ACID TRANSPORT; GENETIC REGULATION; GLUCOSE CLAMP TECHNIQUE; INSULIN RESISTANCE; LIPID DIET; LIPID STORAGE; LIVER METABOLISM; MALE; METABOLIC REGULATION; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RAT; REAL TIME POLYMERASE CHAIN REACTION; SKELETAL MUSCLE; TISSUE LEVEL; TISSUE SPECIFICITY; TRIACYLGLYCEROL BLOOD LEVEL;

ADIPOSE TISSUE; ANIMALS; ANTILIPEMIC AGENTS; BLOOD GLUCOSE; CARNITINE O-PALMITOYLTRANSFERASE; CAROTENOIDS; DIETARY FATS; DISEASE MODELS, ANIMAL; DYSLIPIDEMIAS; FATTY ACIDS, NONESTERIFIED; GLUCOSE CLAMP TECHNIQUE; INSULIN; INSULIN RESISTANCE; LIPASE; LIPOPROTEIN LIPASE; LIPOPROTEINS; LIVER; MALE; MUSCLE, SKELETAL; OXIDATION-REDUCTION; POLYMERASE CHAIN REACTION; RATS; RATS, WISTAR; RNA, MESSENGER; TIME FACTORS; TRIGLYCERIDES;

EID: 46249132352     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1038/bjp.2008.160     Document Type: Article

References (44)

1. Achouri Y, Hegarty BD, Allanic D (2005). Long chain fatty acyl CoA synthetase 5 expression is induced by insulin and glucose: involvement of sterol regulatory element-binding protein-1c. Biochimie 87: 1149-1155.
2. Applebaum-Bowden D (1995). Lipases and lecithin: cholesterol acyltransferase in the control of lipoprotein metabolism. Curr Opin Lipidol 6: 130-135.
3. Bieber LL, Abraham T, Helmarath T (1972). A rapid spectrophotometric assay for carnitine palmitoyltransferase. Anal Biochem 50: 509-518.
4. Chakrabarti R, Vikramadithyan RK, Misra P (2003). Ragaglitazar: a novel PPARα and PPARγ agonist with potent lipid lowering and insulin-sensitizing efficacy in animal models. Br J Pharmacol 140: 527-537.
5. Chalvardjian A (1970). Agarose-starch gel electrophoresis of rat serum lipoproteins. J Lipid Res 12: 156-169.
6. Chavez JA, Summers SA (2003). Characterizing the effects of saturated fatty acids on insulin signaling and ceramide and diacylglycerol accumulation in 3T3-L1 adipocytes and C2C12 myotubes. Arch Biochem Biophys 419: 101-109.
7. Clark PW, Jenkins AB, Kraegen EW (1990). Pentobarbital reduces basal liver glucose output and its insulin suppression in rats. Am J Physiol 258: E701-E707.
8. Connelly PW (1999). The role of hepatic lipase in lipoprotein metabolism. Clin Chim Acta 286: 243-255.
9. Cooney GJ, Thompson AL, Furler SM, Ye J EW K (2002). Muscle long-chain acyl CoA esters and insulin resistance. Ann NY Acad Sci 967: 196-207.
10. DeFronzo RA, Jacot E, Jequier E, Maeder E,Wahren J, Felber JP (1981). The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes 30: 1000-1007.
11. Demacker PN, Hessels M, Toenhake-Dijkstra H, Baadenhuijsen H (1997). Precipitation methods for high-density lipoprotein cholesterol measurement compared and final evaluation under routine operating conditions of a method with a low sample-to-reagent ratio. Clin Chem 43: 663-668.
12. Demacker PN, Hljmans AG, Brenninkmeljer BJ, Jansen AP, Laar AV (1984). Five Methods for determining low-density lipoprotein cholesterol compared. Clin Chem 30: 1797-1800.
13. Deng Y, Qian Z, Tang F (2004). Effects of crocetin on experimental atherosclerosis in rats. Chin Tradition Herbal Drugs 35: 777-781.
14. Doha KO, Kima YW, Parka SY, Leea SK, Parkb JS, Kim JY (2005). Interrelation between long-chain fatty acid oxidation rate and carnitine palmitoyltransferase 1 activity with different isoforms in rat tissues. Life Sci 77: 435-443.
15. Duran-Sandoval D, Mautino G, Martin G, Percevault F, Barbier O, Fruchart JC et al. (2004). Glucose regulates the expression of the farnesoid X receptor in liver. Diabetes 53: 890-898.
16. Escher P, Wahli W (2000). Peroxisome proliferator-activated receptors: insight into multiple cellular functions. Mutat Res 448: 121-138.
17. Guerre-Millo M, Gervois P, Raspe E (2000). Peroxisome proliferator-activated receptor α activators improve insulin sensitivity and reduce adiposity. J Biol Chem 275: 16638-16642.
18. He S, Qian Z, Wen N, Tang F, Xu G, Zhou C (2007). Influence of Crocetin on experimental atherosclerosis in hyperlipidaemic-diet quails. Eur J Pharmacol 554: 191-195.
19. Hegarty BD, Cooney GJ, Kraegen EW, Furler SM (2002). Increased efficiency of fatty acid uptake contributes to lipid accumulation in skeletal muscle of high fat-fed insulin-resistant rats. Diabetes 51: 1477-1484.
20. Hegarty BD, Furler SM, Oakes ND, Kraegen EW, Cooney GJ (2004). Peroxisome proliferator-activated receptor (PPAR) activation induces tissue-specific effects on fatty acid uptake and metabolism in vivo - a study using the novel PPARα/γ agonist tesaglitazar. Endocrinology 145: 3158-3164.
21. Hertz R, Bishara-Shieban J, Bar-Tana J (1995). Mode of action of peroxisome proliferators as hypolipidaemic drugs, suppression of apolipoprotein C-III. J Biol Chem 270: 13470-13475.
22. Hosokawa Y, Shimomura Y, Harris RA (1989). Determination of short-chain acyl CoA esters by high-performance liquid chromatography. Anal Biochem 153: 45-49.
23. Iverius PH, Lindqvist AMO (1986). Preparation, characterization and measurement of lipoprotein lipase. Methods Enzymol 129: 691-704.
24. Jansen H, Breedveld B, Schoonderwoerd K (1998). Role of lipoprotein lipases in postprandial lipid metabolism. Atherosclerosis 141 (Suppl 1): S31-S34.
25. Kaluzny MA, Duncan LA, Merritt MV, Eppse DE (1985). Rapid separation of lipid classes in high yield and purity using bonded phase columns. J Lipid Res 26: 135-140.
26. Kliewer SA, Umesono K, Noonan DJ, Heyman RA, Evans RM (1992). Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors. Nature 358: 771-774.
27. Kraegen EW, James DE, Bennett SP, Chisholm DJ (1983). In vivo insulin sensitivity in the rat determined by euglycaemic clamp. Am J Physiol 245: E1-E7.
28. -ΔΔCT method. Methods 25: 402-408.
29. Louet JF, Chatelain F, Decaux JF, Park EA, Kohl C, Pineau T et al. (2001). Long-chain fatty acids regulate liver carnitine palmitoyl-transferase 1 gene (L-CPT 1) expression through a peroxisome-proliferator-activated receptor α(PPARα)-independent pathway. Biochem J 354: 189-197.
30. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951). Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275.
31. Martin G, Schoonjans K, Lefebvre AM, Staels B, Auwerx J (1997). Coordinate regulation of the expression of the fatty acid transport protein and acyl-CoA synthetase genes by PPARα and PPARγ activators. J Biol Chem 272: 28210-28217.
32. Moody DE, Reddy JK, Lake BG, Popp JA, Reese DH (1991). Peroxisome proliferation and non-genotoxic carcinogenesis: commentary on a symposium. Fund Appl Toxicol 6: 233-248.
33. Motojima K, Passilly P, Peters JM, Gonzalez FJ, Latruffe N (1998). Expression of putative fatty acid transporter genes are regulated by peroxisome proliferator-activated receptor α and γ activators in a tissue- and inducer specific manner. J Biol Chem 273: 16710-16714.
34. Oakes ND, Camilleri S, Furler SM, Chisholm DJ, Kraegen EW (1997). The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism 46: 935-942.
35. Oakes ND, Kjellstedt A, Forsberg GB (1999). Development and initial evaluation of a novel method for assessing tissue-specific plasma free fatty acid utilization in vivo using (R)-2-bromopalmitate tracer. J Lipid Res 40: 1155-1169.
36. Oakes ND, Thalén PG, Jacinto SM, Ljung B (2001). Thiazolidinediones increase plasma-adipose tissue NEFA exchange capacity and enhance insulin-mediated control of systemic NEFA availability. Diabetes 50: 1158-1165.
37. Ringseis R, Muschick A, Eder K (2007). Dietary oxidized fat prevents ethanolinduced triacylglycerol accumulation and increases expression of PPARα target genes in rat liver. J Nutr 137: 77-83.
38. Schmitz PC, Browne CL, Oakes ND (1997). Alterations in the expression and cellular localization of protein kinase C isozymes epsilon and theta are associated with insulin resistance in skeletal muscle of the high-fat-fed rat. Diabetes 46: 169-178.
39. Schoonjans K, Peinado-Onsurbe J, Lefebvre AM, Heyman RA, Briggs M, Deeb S et al. (1996). PPARα and PPARγ activators direct a distinct tissue-specific transcriptional response via a PPRE in the lipoprotein lipase gene. EMBO J 15: 5336-5348.
40. Schoonjans K, Watanabe M, Suzuki H, Mahfoudi A, Krey G, Wahli W et al. (1995). Induction of the acyl-coenzyme A synthetase gene by fibrates and fatty acids is mediated by a peroxisome proliferator response element in the C promoter. J Biol Chem 270: 19269-19276.
41. Shulman GI (2000). Cellular mechanisms of insulin resistance. J Clin Invest 106: 171-176.
42. Turinsky J, O'Sullivan DM, Bayly BP (1990). 1,2-Diacylglycerol and ceramide levels in insulin-resistant tissues of the rat in vivo. J Biol Chem 265: 16880-16885.
43. Xi L, Qian Z, Xu G, Zheng S, Sun S, Wen N et al. (2007). Beneficial impact of crocetin, a carotenoid from saffron, on insulin sensitivity in fructose-fed rats. J Nutr Biochem 18: 64-72.
44. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW (2001). Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: comparison with PPAR-γ activation. Diabetes 50: 411-417.